Esophageal ulcer of Crohn's disease: Disappearance in 1 week with infliximab
โ Scribed by Mitsuro Chiba; Takeshi Sugawara; Hidehiko Tsuda; Toru Abe; Takuo Tokairin; Yuji Kashima
- Publisher
- John Wiley and Sons
- Year
- 2009
- Tongue
- English
- Weight
- 90 KB
- Volume
- 15
- Category
- Article
- ISSN
- 1078-0998
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
Background: Infliximab therapy has short-term benefits in children with moderate-to-severe Crohn's disease (CD). We assessed the long-term outcome of infliximab maintenance therapy in children with CD. ## Methods: We performed a multicenter cohort study of 729 pediatric patients with CD enrolled i
Background: Infliximab (IFX) treatment induces mucosal healing (MH) in patients with Crohn's disease (CD) but the impact of MH on the long-term outcome of IFX treatment in CD is still debated. ## Methods: We studied MH during long-term treatment with IFX in 214 CD patients. A total of 183 patients